Total Payments
$117,864
2024 Payments
$5,622
Companies
55
Transactions
762
Medicare Patients
57,025
Medicare Billing
$3.4M
Payment Breakdown by Category
Other$93,200 (79.1%)
Food & Beverage$16,047 (13.6%)
Consulting$5,816 (4.9%)
Travel$2,629 (2.2%)
Education$172.02 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $93,200 | 71 | 79.1% |
| Food and Beverage | $16,047 | 651 | 13.6% |
| Consulting Fee | $5,816 | 4 | 4.9% |
| Travel and Lodging | $2,629 | 31 | 2.2% |
| Education | $172.02 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $42,644 | 103 | $0 (2024) |
| Allergan, Inc. | $27,424 | 110 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $17,944 | 48 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $7,090 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,954 | 25 | $0 (2024) |
| ABBVIE INC. | $3,568 | 27 | $0 (2023) |
| Lilly USA, LLC | $2,317 | 28 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $1,516 | 9 | $0 (2017) |
| GlaxoSmithKline, LLC. | $1,290 | 84 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $839.75 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,622 | 36 | Janssen Pharmaceuticals, Inc ($4,786) |
| 2023 | $7,621 | 53 | Janssen Pharmaceuticals, Inc ($6,724) |
| 2022 | $27,966 | 102 | Janssen Pharmaceuticals, Inc ($19,958) |
| 2021 | $14,030 | 124 | Janssen Pharmaceuticals, Inc ($8,021) |
| 2020 | $7,556 | 97 | Allergan, Inc. ($6,131) |
| 2019 | $8,570 | 87 | Allergan Inc. ($7,373) |
| 2018 | $13,831 | 113 | Novartis Pharmaceuticals Corporation ($7,047) |
| 2017 | $32,669 | 150 | Novartis Pharmaceuticals Corporation ($10,720) |
All Payment Transactions
762 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: UROLOGY | ||||||
| 10/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Hematology | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $120.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,240.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,240.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 58 | 8,081 | 16,312 | $1.7M | $693,231 |
| 2022 | 77 | 9,688 | 18,485 | $1.8M | $727,092 |
| 2021 | 81 | 15,237 | 31,040 | $2.1M | $864,975 |
| 2020 | 85 | 24,019 | 50,095 | $2.8M | $1.2M |
Total Patients
57,025
Total Services
115,932
Medicare Billing
$3.4M
Procedure Codes
301
All Medicare Procedures & Services
301 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 334 | 1,175 | $213,850 | $99,873 | 46.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 225 | 1,177 | $157,718 | $73,233 | 46.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 134 | 1,025 | $120,950 | $58,300 | 48.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 321 | 427 | $155,001 | $57,113 | 36.8% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 25 | 55 | $178,255 | $45,859 | 25.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 303 | 397 | $76,621 | $35,744 | 46.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 77 | 745 | $74,500 | $34,533 | 46.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 234 | 351 | $62,478 | $32,633 | 52.2% |
| 36466 | Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | Office | 2023 | 13 | 26 | $88,400 | $28,009 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 185 | 185 | $35,150 | $22,885 | 65.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 374 | 1,003 | $49,147 | $16,509 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 247 | $29,887 | $14,924 | 49.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 76 | 177 | $27,435 | $14,047 | 51.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 376 | 1,051 | $40,989 | $13,789 | 33.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 107 | 128 | $29,312 | $13,405 | 45.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 377 | 1,100 | $53,900 | $11,385 | 21.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 99 | 102 | $30,804 | $10,023 | 32.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 134 | $51,858 | $9,105 | 17.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 360 | 984 | $25,584 | $8,699 | 34.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 382 | 1,134 | $26,082 | $8,624 | 33.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 49 | 54 | $20,304 | $7,257 | 35.7% |
| 82172 | Apolipoprotein level | Office | 2023 | 161 | 324 | $9,720 | $6,697 | 68.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 32 | 37 | $10,249 | $5,847 | 57.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 142 | 144 | $10,800 | $5,825 | 53.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 38 | 38 | $11,324 | $5,556 | 49.1% |
About Dr. Jayanti Panchal, M.D
Dr. Jayanti Panchal, M.D is a Internal Medicine healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164458758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayanti Panchal, M.D has received a total of $117,864 in payments from pharmaceutical and medical device companies, with $5,622 received in 2024. These payments were reported across 762 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($93,200).
As a Medicare-enrolled provider, Panchal has provided services to 57,025 Medicare beneficiaries, totaling 115,932 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 301 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Ocala, FL
- Active Since 06/24/2006
- Last Updated 08/31/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164458758
Products in Payments
- XARELTO (Drug) $42,640
- LINZESS (Drug) $22,191
- ENTRESTO (Drug) $17,944
- JARDIANCE (Drug) $9,028
- UBRELVY (Drug) $7,993
- Kerendia (Drug) $7,090
- Uloric (Drug) $1,450
- TRELEGY ELLIPTA (Drug) $1,184
- Linzess (Drug) $652.92
- Vascepa (Drug) $460.91
- VIBERZI (Drug) $374.85
- FARXIGA (Drug) $338.76
- VRAYLAR (Drug) $313.78
- VOQUEZNA (Drug) $274.91
- Ozempic (Drug) $272.10
- ZENPEP (Drug) $262.81
- MAKO (Device) $253.05
- REXULTI (Drug) $240.83
- Trintellix (Drug) $234.25
- BYSTOLIC (Drug) $213.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ocala
Anil Gogineni, M.d, M.D
Internal Medicine — Payments: $174,038
Internal Medicine $174,038
Dr. Andrew Seevaratnam, M.d, M.D
Internal Medicine — Payments: $46,620
Internal Medicine $46,620
Dr. Jose Roman, Md, MD
Internal Medicine — Payments: $31,511
Internal Medicine $31,511
Premranjan Singh, Md, MD
Internal Medicine — Payments: $29,195
Internal Medicine $29,195
Ivan Soosaipillai, Md, MD
Internal Medicine — Payments: $24,570
Internal Medicine $24,570
Dr. Mohamed Suliman, Md, MD
Internal Medicine — Payments: $24,006
Internal Medicine $24,006